What drove the pre-market move in ECT.AS stock today?

The pre-market rise to **€13.30** (+10.83%) was driven by above-average volume (**407** vs **175** avg), technical support near the 50-day average **€12.89**, and renewed interest in Eurocastle’s strong cash and book-value metrics.

What is Meyka AI’s forecast for ECT.AS stock?

Meyka AI's forecast model projects a 12-month target of **€16.58** and a quarterly level **€14.45**, implying about **24.74%** upside from **€13.30**. Forecasts are model-based and not guarantees.

How does Eurocastle’s valuation compare with its sector?

Eurocastle’s price-to-book **0.63** is well below the Financial Services sector average PB of **2.33**, indicating a deep discount versus peers, though negative EPS and thin liquidity raise valuation risk.

When is the next earnings announcement for ECT.AS?

Eurocastle’s next scheduled earnings announcement is on **22 Apr 2026**. That release is a likely volatility trigger for ECT.AS stock as investors reassess NAV and performance.

EU Stocks

ECT.AS Eurocastle (EURONEXT) +10.83% pre-market 23 Jan 2026: volume spike

ByHuzaifa Zahoor January 23, 2026

ECT.AS stock leads high-volume movers in pre-market trading after a €1.30 rise to €13.30, a 10.83% gain on 23 Jan 2026. Volume is 407 versus an average of 175, giving a relative volume of 2.33 and signalling outsized interest. The move follows short-term technical support around the 50-day average €12.89 and renewed investor focus on Eurocastle’s cash-rich balance sheet. We examine drivers, valuation, and Meyka AI’s forecast so traders can weigh risk and opportunity ahead of the next company update.